Cargando…
Analysis of the improvement of serological indexes in patients with diabetic nephropathy and hypertension using Valsartan combined with Nifedipine controlled-release regimen
OBJECTIVE: To investigate the effect of valsartan combined with nifedipine controlled-release Tablets on diabetic nephropathy (DN) patients with hypertension. METHODS: The clinical records of 80 DN patients with hypertension registered in our hospital from April 2020 to April 2021 were collected. Th...
Autores principales: | Cai, Lili, Zhu, Haili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378412/ https://www.ncbi.nlm.nih.gov/pubmed/35991228 http://dx.doi.org/10.12669/pjms.38.6.5871 |
Ejemplares similares
-
Efficacies of Controlling Morning Blood Pressure and Protecting the Kidneys by Treatment With Valsartan and Nifedipine CR or Valsartan and Amlodipine (MONICA Study)
por: Tanaka, Tohru, et al.
Publicado: (2013) -
Cost-effectiveness analysis of combining traditional Chinese medicine in the treatment of hypertension: compound Apocynum tablets combined with Nifedipine sustained-release tablets vs Nifedipine sustained-release tablets alone
por: Xu, Qian, et al.
Publicado: (2020) -
Magnesium Sulfate in combination with Nifedipine in the treatment of Pregnancy-Induced Hypertension
por: Xiang, Cuiping, et al.
Publicado: (2020) -
Aliskiren and valsartan combination therapy for the management of hypertension
por: Epstein, Benjamin J
Publicado: (2010) -
Sacubitril/Valsartan Shows Improvement of the Cardio-Ankle Vascular Index in a Hypertensive Patient
por: Shimizu, Kazuhiro, et al.
Publicado: (2023)